{"nctId":"NCT02247804","briefTitle":"Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension","startDateStruct":{"date":"2014-12-15","type":"ACTUAL"},"conditions":["Glaucoma, Open-Angle","Ocular Hypertension"],"count":594,"armGroups":[{"label":"Bimatoprost SR 15 μg","type":"EXPERIMENTAL","interventionNames":["Drug: Bimatoprost SR","Drug: Active Comparator: Timolol 0.5%","Other: Sham: Applicator Without Needle","Drug: Timolol Vehicle (placebo)"]},{"label":"Bimatoprost SR 10 μg","type":"EXPERIMENTAL","interventionNames":["Drug: Bimatoprost SR","Drug: Active Comparator: Timolol 0.5%","Other: Sham: Applicator Without Needle","Drug: Timolol Vehicle (placebo)"]},{"label":"Timolol 0.5%","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Active Comparator: Timolol 0.5%","Other: Sham: Applicator Without Needle"]}],"interventions":[{"name":"Bimatoprost SR","otherNames":["AGN-192024"]},{"name":"Active Comparator: Timolol 0.5%","otherNames":[]},{"name":"Sham: Applicator Without Needle","otherNames":[]},{"name":"Timolol Vehicle (placebo)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n-Diagnosis of either open-angle glaucoma or ocular hypertension in each eye and both eyes require IOP-lowering treatment.\n\nExclusion Criteria:\n\n* Previous enrollment in another Allergan Bimatoprost SR Study.\n* Eye surgery (including cataract surgery) and/or any eye laser surgery within the past 6 months in the study eye\n* Anticipated need for laser eye surgery in either eye within the first 52 weeks of the study duration\n* History of glaucoma surgery","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in IOP in the Study Eye at Week 12 (Hours 0 and 2)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. A mixed-effects model with repeated measures (MMRM) was used for analyses. A negative change from baseline indicates an improvement and a positive change from baseline indicates a worsening.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.46","spread":"0.29"},{"groupId":"OG001","value":"-6.38","spread":"0.28"},{"groupId":"OG002","value":"-6.05","spread":"0.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.18","spread":"0.26"},{"groupId":"OG001","value":"-6.69","spread":"0.25"},{"groupId":"OG002","value":"-6.48","spread":"0.25"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 2 (Hour 0)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.82","spread":"0.25"},{"groupId":"OG001","value":"17.02","spread":"0.25"},{"groupId":"OG002","value":"17.83","spread":"0.25"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 2 (Hour 2)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.48","spread":"0.22"},{"groupId":"OG001","value":"16.42","spread":"0.22"},{"groupId":"OG002","value":"17.33","spread":"0.22"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 6 (Hour 0)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.08","spread":"0.24"},{"groupId":"OG001","value":"16.88","spread":"0.23"},{"groupId":"OG002","value":"17.71","spread":"0.24"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 6 (Hour 2)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.62","spread":"0.23"},{"groupId":"OG001","value":"16.51","spread":"0.22"},{"groupId":"OG002","value":"17.16","spread":"0.23"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 12 (Hour 0)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.53","spread":"0.29"},{"groupId":"OG001","value":"17.61","spread":"0.28"},{"groupId":"OG002","value":"17.94","spread":"0.28"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 12 (Hour 2)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.81","spread":"0.26"},{"groupId":"OG001","value":"17.30","spread":"0.25"},{"groupId":"OG002","value":"17.51","spread":"0.25"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in IOP in the Study Eye","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses. A negative change from baseline indicates an improvement and a positive change from baseline indicates a worsening.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.17","spread":"0.25"},{"groupId":"OG001","value":"-6.97","spread":"0.25"},{"groupId":"OG002","value":"-6.17","spread":"0.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.52","spread":"0.22"},{"groupId":"OG001","value":"-7.57","spread":"0.22"},{"groupId":"OG002","value":"-6.67","spread":"0.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.91","spread":"0.24"},{"groupId":"OG001","value":"-7.11","spread":"0.23"},{"groupId":"OG002","value":"-6.29","spread":"0.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.37","spread":"0.23"},{"groupId":"OG001","value":"-7.48","spread":"0.22"},{"groupId":"OG002","value":"-6.83","spread":"0.23"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":31,"n":193},"commonTop":["Conjunctival hyperaemia","Eye irritation","Foreign body sensation in eyes","Eye pain","Conjunctival haemorrhage"]}}}